ALHYG ready for impulsive moveHi everyone,
the price range is narrowing and rotate around 0.3 value, it seems that we are ready for an impulse distribution.
Mar 25th POC at 0.29 should offer support.
Possible target 0.7.
−500.00 KEUR
220.82 M
About HYBRIGENICS
Sector
CEO
Léone Atayi
Headquarters
Gallargues-le-Montueux
Website
Founded
1998
ISIN
FR0004153930
FIGI
BBG000TXWWM5
Hybrigenics SA operates as a biopharmaceutical company which engages in the research and development of targets and therapies for the treatment of proliferative diseases. It develops inecalcitol for the treatment of prostate cancer, acute and chronic lymphocytic leukemia, and acute and chronic myeloid leukemia. The company was founded by Arthur Donny Strosberg on December 29, 1997 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALHYG is 0.0118 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange HYBRIGENICS stocks are traded under the ticker ALHYG.
ALHYG stock is 2.54% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is HYBRIGENICS there?
Yes, you can track HYBRIGENICS financials in yearly and quarterly reports right on TradingView.
ALHYG stock has fallen by 3.28% compared to the previous week, the month change is a 7.09% fall, over the last year HYBRIGENICS has showed a 81.27% decrease.
No, ALHYG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALHYG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYBRIGENICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HYBRIGENICS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HYBRIGENICS stock shows the sell signal. See more of HYBRIGENICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.